Literature DB >> 11162643

Chromosomal localization, expression pattern, and promoter analysis of the mouse gene encoding adipocyte-specific secretory protein Acrp30.

K Das1, Y Lin, E Widen, Y Zhang, P E Scherer.   

Abstract

Acrp30 is an abundantly expressed secretory protein exclusively synthesized in adipose tissue. Due to the dysregulation in various forms of obesity in humans and mice and its strong structural similarity to TNFalpha, it is currently under study as an important molecule involved in whole body energy homeostasis. Here we describe the sequence of mouse Acrp30 locus, define the intron/exon boundaries and map the gene to the telomere of mouse chromosome 16, syntenic to the human chromosomal locus 3q27. We demonstrate that alternative polyadenylation gives rise to two distinct mRNA species. We also show that Acrp30 expression is induced only at the late stages of mouse embryonic development. Finally, we have characterized the mouse Acrp30 promoter in tissue culture cells. We propose that Acrp30 promoter has the potential to drive strong adipocyte specific heterologous gene expression in transgenic mice. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162643     DOI: 10.1006/bbrc.2001.4217

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Adipokines as novel biomarkers and regulators of the metabolic syndrome.

Authors:  Yingfeng Deng; Philipp E Scherer
Journal:  Ann N Y Acad Sci       Date:  2010-11       Impact factor: 5.691

2.  Identification and characterization of a promoter cassette conferring adipocyte-specific gene expression.

Authors:  Zhao V Wang; Yingfeng Deng; Qiong A Wang; Kai Sun; Philipp E Scherer
Journal:  Endocrinology       Date:  2010-04-02       Impact factor: 4.736

Review 3.  Signal transductions and nonalcoholic fatty liver: a mini-review.

Authors:  Lu Zeng; Wai J Tang; Jin J Yin; Bei J Zhou
Journal:  Int J Clin Exp Med       Date:  2014-07-15

Review 4.  Hypoadiponectinaemia in diabetes mellitus type 2: molecular mechanisms and clinical significance.

Authors:  Hui Su; Wayne Bond Lau; Xin-Liang Ma
Journal:  Clin Exp Pharmacol Physiol       Date:  2011-12       Impact factor: 2.557

5.  Possible role of microsomal epoxide hydrolase gene polymorphism as a risk factor for developing insulin resistance and type 2 diabetes mellitus.

Authors:  Maivel H Ghattas; Mahmoud A Amer
Journal:  Endocrine       Date:  2012-05-04       Impact factor: 3.633

6.  Effects of DGAT1 deficiency on energy and glucose metabolism are independent of adiponectin.

Authors:  Ryan S Streeper; Suneil K Koliwad; Claudio J Villanueva; Robert V Farese
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-04-04       Impact factor: 4.310

Review 7.  APPL1: role in adiponectin signaling and beyond.

Authors:  Sathyaseelan S Deepa; Lily Q Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

8.  Biomarkers of adiponectin: plasma protein variation and genomic DNA polymorphisms.

Authors:  Harvest F Gu
Journal:  Biomark Insights       Date:  2009-10-13

9.  Pre- and post-translational negative effect of beta-adrenoceptor agonists on adiponectin secretion: in vitro and in vivo studies.

Authors:  Marie-Laure Delporte; Tohru Funahashi; Masahiko Takahashi; Yuji Matsuzawa; Sonia M Brichard
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

10.  Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin action.

Authors:  Vanita Aroda; Theodore P Ciaraldi; Sang-Ah Chang; Michael H Dahan; R Jeffrey Chang; Robert R Henry
Journal:  Fertil Steril       Date:  2007-08-13       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.